Table 3.
Molecules Inducing Apoptosis in MSCs and Corresponding Rescue Methods.
| Pro-apoptotic molecules | Rescue methods | Mechanisms | Refs |
|---|---|---|---|
| Hypoxia/Serum deprivation | Overexpression of Lnc Tmem235 | Regulate the miR-34a-3p/BIRC5 axis | [138] |
| Andrographolide | Via NRF2 signaling pathway | [142] | |
| Overexpression of miR-21, miR-23a and miR-210 | [165] | ||
| Adjunction of adenosine triphosphate | prevent caspases 3/7 activation and modulate ERK1/2 and p38 MAPK signaling pathways | [166] | |
| BNIP3-mediated mitophagy | Promote fatty acid synthase -induced free fatty acid synthesis | [167] | |
| Overexpression of LncAABR07053481 | Regulate the miR-664-2-5p/Notch1 pathway | [168] | |
| H2O2 | IL-11 | Activate STAT3 signaling | [139] |
| PGE1 pretreatment | Regulate the HIF pathway | [143] | |
| Overexpression of NMNAT3 | Improve mitochondrial function and enhance antioxidative stress capacity by NMNAT3-NAD + -SIRT3 axis | [144] | |
| SDF-1 pretreatment | Activate the pro-survival AKT and ERK signaling pathways and upregulate Bcl-2/Bax ratio | [169] | |
| Overexpression of miR-210 | Through antioxidation and c-Met pathway activation | [170] | |
| Exendin-4 pretreatment | Through the PI3K/AKT–secreted frizzled-related protein 2 pathway | [171] | |
| Melatonin/ Astaxanthin | Via NRF2 signaling pathway | [172, 173] | |
| Fucoxanthin | Through the PI3K/AKT/ NRF2 pathway | [174] | |
| Dexamethasone | Baicalin | Active the hedgehog signaling pathway | [140] |
| Eicosapentaenoic acid | Via GPR120-meditated induction of adaptive autophagy | [175] | |
| Metformin | Facilitate osteogenesis and inhibit adipogenesis | [141] | |
| LNC_000052 | Upregulation of miR-96-5p | Via the PI3K/AKT signaling pathway | [145] |
| Glutamate | Repress prostate apoptosis response-4 gene expression | [176] | |
| TNF-α | Silence RUNX2 | Inhibit caspase-3 activity and Bax expression | [177] |
| CoCl2 and SIN-1 | Transfection of miR-302d | Inhibit CCL-5 expression | [178] |
| Diabetic serum | Blockade of the C5a/C5aR pathway | Down-regulation of FADD and the Bax/ Bcl-2 ratio | [179] |
| High glucose stress | AURKA | Transcriptional regulation for FOXO3a | [180] |
| Ropivacaine | Sufentanil | Regulate miR- 182-5p/BCL10/CYCS | [181] |
| Ionizing radiation | Redd1 overexpression | Attenuate mitochondrial ROS generation and promote cell autophagy | [182] |
| Methylprednisolone | Parkinson disease protein 7 | Via NRF2 signaling pathway | [183] |
MSCs mesenchymal stem cells, miR micro RNA, BIRC5 baculoviral IAP repeat-containing protein 5, NRF2 Nuclear factor-erythroid 2 related factor 2, ERK extracellular regulated protein kinases, MAPK mitogen-activated protein kinase, BNIP3 Bcl-2/adenovirus E1B 19 kDa protein-interacting protein 3, H2O2 hydrogen peroxide, PGE1 prostaglandin E2, HIF hypoxia-inducible factor, NMNAT3 nicotinamide mononucleotide adenylyl transferase 3, SDF-1 Stromal cell-derived factor 1, NAD+ nicotinamide adenine dinucleotide, SIRT3 Sirtuin 3, PI3K Phosphatidylinositol 3-kinase, GPR120 G protein coupled receptor 120, TNF-α tumor necrosis factor-alpha, RUNX2 Runt-related transcription factor 2, CoCl2 cobalt chloride, SIN-1 3-morpholinosydnonimine hydrochloride, CCL-5 C-C motif chemokine ligand 5, C5a/C5aR complement C5a/C5a receptor, FADD Fas-associated protein with death domain, Fas-L Fas ligand, BCL10 B-cell lymphoma/leukemia10, CYCS cytochrome c, somatic.